Nothing Special   »   [go: up one dir, main page]

FI956151A0 - Iskeemisissä taudeissa käyttökelpoisia bentseenijohdannaisia - Google Patents

Iskeemisissä taudeissa käyttökelpoisia bentseenijohdannaisia

Info

Publication number
FI956151A0
FI956151A0 FI956151A FI956151A FI956151A0 FI 956151 A0 FI956151 A0 FI 956151A0 FI 956151 A FI956151 A FI 956151A FI 956151 A FI956151 A FI 956151A FI 956151 A0 FI956151 A0 FI 956151A0
Authority
FI
Finland
Prior art keywords
formula
ischemic diseases
derivatives useful
benzene derivatives
chem
Prior art date
Application number
FI956151A
Other languages
English (en)
Swedish (sv)
Other versions
FI956151A (fi
Inventor
Nobuhiro Ohi
Tatsuya Kato
Tomakazu Ozaki
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FI956151A0 publication Critical patent/FI956151A0/fi
Publication of FI956151A publication Critical patent/FI956151A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/64Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D419/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI956151A 1993-06-23 1995-12-20 Iskeemisissä taudeissa käyttökelpoisia bentseenijohdannaisia FI956151A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15224893 1993-06-23
PCT/JP1994/001009 WO1995000471A1 (fr) 1993-06-23 1994-06-23 Derive du benzene utile contre les ischemies

Publications (2)

Publication Number Publication Date
FI956151A0 true FI956151A0 (fi) 1995-12-20
FI956151A FI956151A (fi) 1996-02-19

Family

ID=15536338

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956151A FI956151A (fi) 1993-06-23 1995-12-20 Iskeemisissä taudeissa käyttökelpoisia bentseenijohdannaisia

Country Status (18)

Country Link
EP (1) EP0705816B1 (fi)
KR (1) KR100262419B1 (fi)
CN (1) CN1038582C (fi)
AT (1) ATE196464T1 (fi)
CA (1) CA2165662A1 (fi)
CZ (1) CZ289716B6 (fi)
DE (1) DE69425970T2 (fi)
ES (1) ES2152319T3 (fi)
FI (1) FI956151A (fi)
HU (1) HUT75102A (fi)
NO (1) NO305956B1 (fi)
PL (1) PL176687B1 (fi)
RO (1) RO115518B1 (fi)
RU (1) RU2127254C1 (fi)
SK (1) SK164795A3 (fi)
TW (1) TW403734B (fi)
UA (1) UA43338C2 (fi)
WO (1) WO1995000471A1 (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998452A (en) * 1993-06-23 1999-12-07 Chugai Seiyaku Kabushiki Kaisha Benzene derivatives, compositions and methods for treating ischemic diseases
WO1996019210A1 (fr) * 1994-12-22 1996-06-27 Chugai Seiyaku Kabushiki Kaisha Medicament contre les maladies ischemiques
EP0938676A1 (en) * 1996-11-12 1999-09-01 Eli Lilly And Company Combinatorial process for preparing thiazolidinone libraries
CA2334258A1 (en) 1998-06-05 1999-12-09 Icagen, Inc. Potassium channel inhibitors
US6174908B1 (en) 1999-05-10 2001-01-16 Icagen, Inc. Potassium channel inhibitors
JP2004002206A (ja) * 2000-07-26 2004-01-08 Chugai Pharmaceut Co Ltd 光学活性なチアゾリジノン誘導体の製造方法
CA2453633A1 (en) 2001-07-16 2003-01-30 Euro-Celtique S.A. Aryl substituted thiazolidinones and the use thereof
TW200412948A (en) * 2002-08-23 2004-08-01 Ionix Pharmaceuticals Ltd Therapeutic compounds
FR3120368B1 (fr) * 2021-03-02 2024-01-19 Michelin & Cie Monomères contenant un motif 4-thiazolidinone et leurs polycondensats polyamide, polyester et polyuréthane.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2623048A (en) * 1948-04-05 1952-12-23 Parke Davis & Co 4-thiazolidone derivatives and process for preparing the same
US2520179A (en) * 1949-02-02 1950-08-29 Sterling Drug Inc 4-thiazolidones and a method for preparation thereof
US3309377A (en) * 1964-10-19 1967-03-14 Sterling Drug Inc 3-[(2-oxazolidinone-3-yl)-alkyl]-4-thiazolidinones and their preparation
FR2504528A1 (fr) * 1981-04-23 1982-10-29 Choay Sa Dialcoxy (2,4) benzenesulfonamides n-substitues
US4820715A (en) * 1984-06-28 1989-04-11 Bristol-Myers Company Anti-emetic quinuclidinyl benzamides
PT83152B (pt) 1985-08-09 1989-03-30 Lilly Co Eli Processo para a preparacao de compostos di-t-butilfenoicos
GB8820442D0 (en) * 1988-08-30 1988-09-28 Usherwood P N R Therapeutic polyamine amides
AU7317391A (en) * 1990-02-14 1991-09-03 Chugai Seiyaku Kabushiki Kaisha Inhibitor of denatured ldl formation

Also Published As

Publication number Publication date
SK164795A3 (en) 1996-10-02
EP0705816A1 (en) 1996-04-10
NO955176D0 (no) 1995-12-20
HU9503775D0 (en) 1996-02-28
PL312471A1 (en) 1996-04-29
TW403734B (en) 2000-09-01
WO1995000471A1 (fr) 1995-01-05
DE69425970T2 (de) 2001-01-18
CN1038582C (zh) 1998-06-03
EP0705816B1 (en) 2000-09-20
UA43338C2 (uk) 2001-12-17
NO305956B1 (no) 1999-08-23
ES2152319T3 (es) 2001-02-01
PL176687B1 (pl) 1999-07-30
KR100262419B1 (ko) 2000-09-01
AU674239B2 (en) 1996-12-12
CA2165662A1 (en) 1995-01-05
CZ345095A3 (en) 1996-12-11
RO115518B1 (ro) 2000-03-30
CZ289716B6 (cs) 2002-03-13
DE69425970D1 (de) 2000-10-26
FI956151A (fi) 1996-02-19
HUT75102A (en) 1997-04-28
RU2127254C1 (ru) 1999-03-10
AU6982994A (en) 1995-01-17
NO955176L (no) 1996-02-23
EP0705816A4 (en) 1997-05-28
ATE196464T1 (de) 2000-10-15
CN1127502A (zh) 1996-07-24

Similar Documents

Publication Publication Date Title
DE69716226D1 (de) Difluoroprostaglandin-Derivate und ihre Anwendung
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
EA200200708A1 (ru) Производные бензазола и их применение в качестве модуляторов jnk
PT669920E (pt) 3-aminoalquilamino-1,2-benzoxazoles substituidos ecompostos relacionados
PT1216245E (pt) Derivados sulfonil-hidrazida farmaceuticamente activos
FI956151A0 (fi) Iskeemisissä taudeissa käyttökelpoisia bentseenijohdannaisia
DE69824450D1 (de) Biphenylamidin-derivate
DK0648744T3 (da) Phenylalkanolaminderivater som antagonister for NMDA-receptoren
ATE402151T1 (de) 2-(arylphenyl)amino-imidazolin-derivate
DK0420224T3 (da) Anthihepatopatisk middel
DE69123757D1 (de) Epoxysuccinamidsäurederivat
NO921282L (no) Benzotiazolderivater og deres anvendelse
ATE105565T1 (de) Pradimicinderivate.
ES2149180T3 (es) Derivado de pirazolotiazolopirimidina.